肿瘤坏死因子抑制剂减缓强直性脊柱炎放射学进展:18年真实世界证据
该单中心回顾性研究基于2001至2018年18年纵向真实世界数据,分析338例至少暴露过一次TNFi的强直性脊柱炎患者的2364个治疗间期,采用边际结构模型加权分析发现,TNFi使用期间mSASSS年变化率显著低于未使用期间(β=-0.112,p=0.004),调整后年变化分别为0.848和0.960。
要点
- TNFi使用期间mSASSS年变化率显著低于未使用期间(β=-0.112,p=0.004)。
- 调整后mSASSS年变化:使用TNFi期间0.848,未使用期间0.960。
- 基于18年真实世界纵向数据,TNFi可显著减缓强直性脊柱炎放射学进展。
核心结论
- 与未使用TNFi相比,使用TNFi治疗显著减缓强直性脊柱炎患者的放射学进展。
研究设计与样本
- 单中心回顾性研究,2001年1月至2018年12月,审查1280例电子病历,纳入595例至少暴露一次TNFi的患者。
- 其中338例患者确定了TNFi暴露或非暴露间期,比较「使用TNFi」与「未使用TNFi」间期的mSASSS变化率差异。
主要发现
- 338例患者共获得2364个间期(1281个使用TNFi间期和1083个未使用TNFi间期)。
- 在逆概率治疗加权边际结构模型中,使用TNFi使mSASSS变化率显著降低(β=-0.112,p=0.004)。
- 调整后mSASSS年变化在使用TNFi期间为0.848,在未使用TNFi期间为0.960。
关键数值与推荐
- 使用TNFi期间mSASSS年变化为0.848,未使用期间为0.960。
- TNFi对mSASSS变化率的效应量β=-0.112,p=0.004。
临床怎么用
- 对于强直性脊柱炎患者,长期使用TNFi可能有助于减缓脊柱放射学进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tumour necrosis factor inhibitors (TNFis) have been suggested to slow radiographic progression in patients with ankylosing spondylitis. However, limitations such as variations in disease activity, complex drug administration and short follow-up duration make it difficult to determine the effect of TNFis on radiographic progression. The aim of the study was to investigate whether long-term treatment with TNFis can reduce radiographic progression in patients with ankylosing spondylitis using 18-year longitudinal real-world data. METHODS: This retrospective study was conducted between January 2001 and December 2018 at a single centre. Among the 1280 patients whose electronic medical records were reviewed, data of 595 patients exposed to TNFis at least once were included. Among them, time intervals of TNFi exposure or non-exposure were determined in 338 patients ('on the TNFis' or 'off the TNFis' intervals, respectively). The difference in the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) change rate between 'on the TNFis' and 'off the TNFis' intervals was investigated. RESULTS: We obtained 2364 intervals of 338 patients (1281 'on the TNFis' and 1083 'off the TNFis' intervals). In the marginal structural model for inverse probability of treatment weighting, the change rate of mSASSS significantly decreased with the use of TNFis (β=-0.112, p=0.004), and the adjusted mSASSS changes were 0.848 and 0.960 per year during 'on the TNFis' and 'off the TNFis' intervals, respectively. CONCLUSION: Compared with treatment without TNFis, treatment with TNFis slowed radiologic progression significantly.
引用
- Koo BS, Oh JS, Park SY, et al. Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence. Ann Rheum Dis. 2020. PMID: 32660979. doi:10.1136/annrheumdis-2019-216741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。